Letter to the editor regarding systematic review and meta-analysis of the efficacy of gabapentin in chronic female pelvic pain without another diagnosis
Other
OA: gold
CC0
AI-generated summary
This letter to the editor discusses the systematic review and meta-analysis of gabapentin's efficacy in treating chronic female pelvic pain when no other specific diagnosis is present.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (6)
- Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial via openalex
- Gabapentin for the management of chronic pelvic pain in women via openalex
- Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A Pilot Randomised Controlled Trial via openalex
- Systematic review and meta-analysis of the efficacy of gabapentin in chronic female pelvic pain without another diagnosis via openalex
- The use of brain functional magnetic resonance imaging to determine the mechanism of action of gabapentin in managing chronic pelvic pain in women: a pilot study via openalex
- W6805445989 via openalex
Source provenance
- europepmc
- last seen: 2026-10-11T09:27:45.537177+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:37:06.835816+00:00
License: CC0
· commercial use OK